Term ends Aug 9, 2030 · High confidence
20-year base term ends Aug 9, 2030
Aug 9, 2010
Aug 9, 2030
Apr 22, 2014
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Aug 9, 2010, when application 12/852,706, the earliest non-provisional in its chain, was filed (this one was filed Sep 5, 2013) | Aug 9, 2030 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 8,252,812, US 8,604,052, US 8,664,241, US 8,673,936) | resolves to Aug 9, 2030, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Aug 9, 2030 | High confidence |
This family
| US 8,252,812 | In force Aug 2030 | Aug 2030 |
| US 8,822,478 | In force Sep 2030 | Sep 2030 |
| US 8,604,052 | Lapsed on the fee record Dec 2025 | Dec 2025 |
| US 8,703,794 | this patent Aug 2030 | Aug 2030 |
| US 9,090,613 | In force Aug 2030 | Aug 2030 |
| US 9,381,192 | In force Aug 2030 | Aug 2030 |
| US 9,763,927 | In force Aug 2030 | Aug 2030 |
| US 10,016,406 | Lapsed on the fee record Jul 2026 | Jul 2026 |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Oct 15, 2013 Reel 31403, frame 462 | Hood, John; Wallace, David Mark; Kc, Sunil Kumar | Samumed, LLC | Assignment of Assignor's Interest |
| Mar 23, 2021 Reel 55693, frame 882 | Samumed, LLC | Biosplice Therapeutics, Inc. | Assignment of Assignor's Interest |
| Sep 14, 2022 reel/frame not recorded | Biosplice Therapeutics, Inc. | Vickers Venture Fund VI Pte. Ltd. | Security Interest |
| Sep 14, 2022 reel/frame not recorded | Biosplice Therapeutics, Inc. | Vickers Venture Fund VI (Plan) Pte. Ltd. | Security Interest |
| Sep 14, 2022 reel/frame not recorded | Biosplice Therapeutics, Inc. | Vickers-Splice Co.-Investment LLC | Security Interest |
| Sep 14, 2022 reel/frame not recorded | Biosplice Therapeutics, Inc. | Med-Pathways II Limited | Security Interest |
| Sep 14, 2022 Reel 61433, frame 786 | Biosplice Therapeutics, Inc. | Vickers Venture Fund VI Pte. Ltd.; Vickers Venture Fund VI (Plan) Pte. Ltd.; Vickers-Splice Co.-Investment LLC; Med-Pathways II Limited | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer resolved from the filed document, referencing US 8,252,812, US 8,604,052, US 8,664,241, US 8,673,936, ends no earlier than this term, so it caps nothing.